Surendralal Lanca Karsanbhai - 01 Jan 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: Director
Signature: /s/ Kelly E. W. Grez as Attorney-in-Fact for Surendralal L. Karsanbhai
Issuer symbol: MRK
Transactions as of: 01 Jan 2025
Net transactions value: +$55,000
Form type: 4
Filing time: 03 Jan 2025, 12:59:15 UTC
Previous filing: 15 Nov 2024
Next filing: 09 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						1	01 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Phantom Stock	Award	$55,000	+553		$99.48	553	01 Jan 2025	Common Stock	553		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1-for-1
F2	Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3	The price reported is the closing price of Merck Common Stock on the business day immediately prior to the effective date of the Director's service.